| Literature DB >> 22095134 |
Souhila Alouache1, Mohamed Kada, Yamina Messai, Vanesa Estepa, Carmen Torres, Rabah Bakour.
Abstract
The aim of the study was to evaluate bacterial antibiotic resistance in seawater from four beaches in Algiers. The most significant resistance rates were observed for amoxicillin and ticarcillin, whereas they were relatively low for ceftazidime, cefotaxime and imipenem. According to sampling sites, the highest resistance rates were recorded for 2 sites subjected to chemical and microbiological inputs (amoxicillin, 43% and 52%; ticarcillin, 19.6% and 47.7%), and for 2 sites relatively preserved from anthropogenic influence, resistance rates were lowest (amoxicillin, 1.5% and 16%; ticarcillin, 0.8% and 2.6%). Thirty-four bacteria resistant to imipenem (n=14) or cefotaxime (n=20) were identified as Pseudomonas aeruginosa (n=15), Pseudomonas fluorescens (7), Stenotrophomonas maltophilia (4), Burkholderia cepacia (2), Bordetella sp. (1), Pantoea sp. (1), Acinetobacter baumannii (1), Chryseomonas luteola (1), Ochrobactrum anthropi (1) and Escherichia coli (1). Screening for extended spectrum β-lactamase showed the presence of CTX-M-15 β-lactamase in the E. coli isolate, and the encoding gene was transferable in association with the IncI1 plasmid of about 50 kbp. Insertion sequence ISEcp1B was located upstream of the CTX-M-15 gene. This work showed a significant level of resistance to antibiotics, mainly among environmental saprophytic bacteria. Transmissible CTX-M-15 was detected in E. coli; this may mean that contamination of the environment by resistant bacteria may cause the spread of resistance genes.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22095134 PMCID: PMC4036028 DOI: 10.1264/jsme2.me11266
Source DB: PubMed Journal: Microbes Environ ISSN: 1342-6311 Impact factor: 2.912
Physico-chemical and microbiological parameters of seawater samples
| Parameters | Seawater sampling sites | |||
|---|---|---|---|---|
|
| ||||
| Mouth of Reghaia lake | Ain Chrob | Ain Tagourait | Anse de Kouâli | |
| Salinity (PSU) | 32.2 | 36.8 | 36.8 | 36.7 |
| pH | 8.1 | 8.3 | 8.3 | 8.5 |
| Temperature (°C) | 13.6 | 14.3 | 14.5 | 14.3 |
| Dissolved oxygen (mg L−1) | 7.1 | 7.2 | 8.3 | 10.6 |
| Oxygen saturation (%) | (76%) | (76%) | (81%) | (104%) |
| Suspended matter (mg L−1) | 157.9 | 216.1 | 174.4 | 153.6 |
| Biological oxygen demand (mg L−1) | 5 | 5 | 0 | 0 |
| Total flora (CFU 100 mL−1) | 18,000 | 2,040 | 860 | 3,510 |
| Total coliform (CFU 100 mL−1) | 8,700 | 240 | 37 | 44 |
| Thermotolerant coliform (CFU 100 mL−1) | 400 | 1 | 25 | 19 |
Fig. 1β-Lactam resistance among total flora from beach seawater.
AMX: amoxicillin; TIC: ticarcillin; CTX: cefotaxime; CAZ: ceftazidime; FOX: cefoxitin; IMP: imipenem.
Antibiotic resistance rates among imipenem- or cefotaxime-resistant isolates
| Resistant Isolates | Antibiotics | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||||||||||||||
| β-lactams | Non β-lactams antibiotics | |||||||||||||||||||||||
|
|
| |||||||||||||||||||||||
| AMX | AMC | TIC | TCC | PIP | PTZ | CFS | FOX | CRO | CTX | CAZ | FEP | ATM | IMP | K | GM | SSS | TMP | SXT | TE | CIP | NA | C | RA | |
| Imipenem ( | 14 | 7 | 13 | 10 | 7 | 6 | 13 | 14 | 10 | 12 | 6 | 7 | 8 | 14 | 0 | 0 | 1 | 13 | 1 | 10 | 2 | 12 | 10 | 6 |
| Cefotaxime ( | 20 | 19 | 20 | 18 | 2 | 1 | 17 | 19 | 20 | 20 | 11 | 6 | 17 | 1 | 1 | 0 | 2 | 15 | 4 | 4 | 0 | 17 | 9 | 0 |
| Total ( | 34 | 26 | 33 | 28 | 9 | 7 | 30 | 33 | 30 | 32 | 17 | 13 | 25 | 15 | 1 | 0 | 3 | 28 | 5 | 14 | 2 | 29 | 19 | 6 |
| Resistance rate (%) | 100 | 76.4 | 97 | 82.3 | 26.4 | 20.5 | 88.2 | 97 | 88.2 | 94.1 | 50 | 38.2 | 73.5 | 44.1 | 2.9 | 0 | 8.8 | 82.3 | 14.7 | 41.1 | 5.8 | 85.2 | 55.8 | 17.6 |
AMX, amoxicillin; AMC, amoxicillin/clavulanate; TIC, ticarcillin; TCC, ticarcillin/clavulanate; PIP, piperacillin; PTZ, piperacillin/tazobactam; CFS, cefsulodine; FOX, cefoxitin; CRO, ceftriaxone; CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepim; ATM, aztreonam; IMP, imipenem; K, kanamycin; GM, gentamycin; SSS, sulfonamide; TMP, trimethoprim; SXT, trimethoprim/sulfamethoxazole; TE, tetracycline; CIP, ciprofloxacin; NA, nalidixic acid; C, chloramphenicol; RA, rifampicin.
Antibiotic resistance traits of cefotaxime- and imipenem-resistant isolates
| Imipenem- or cefotaxime-esistant isolates | Isolate | Origin | Resistance traits | Number of resistance traits | ESBL test |
|---|---|---|---|---|---|
| Imipenem-resistant isolates | I1: | Ain Tagourait | AMX-TIC-TCC-CFS-FOX-IMP-TMP-NA-RA | 09 | − |
| I2: | Ain Chrob | AMX-AMC-FOX-CTX-IMP-TMP-SXT-TE-CIP-NA-C | 11 | − | |
| I3: | Ain Tagourait | AMX-TIC-TCC-CFS-FOX-CRO-CTX-ATM-IMP-TMP-C | 11 | − | |
| I4: | Mouth of Reghaia lake | AMX-TIC-TCC-CFS-FOX-IMP-TMP-TE-NA-C-RA | 11 | − | |
| I5: | Ain Chrob | AMX-TIC-TCC-CFS-FOX-CTX-IMP-TMP-TE-NA-C-RA | 12 | − | |
| I6: | Ain Chrob | AMX-TIC-TCC-CFS-FOX-CRO-CTX-IMP-TMP-TE-NA-C-RA | 13 | − | |
| I7: | Ain Chrob | AMX-AMC-TIC-PIP-PTZ-CFS-FOX-CRO-CTX-FEP-ATM-IMP-NA | 13 | − | |
| I8: | + | ||||
| I9: | Mouth of Reghaia lake | AMX-AMC-TIC-TCC-PIP-PTZ-CFS-FOX-CRO-CTX-CAZ-FEP-ATM-IMP-TMP | 15 | + | |
| I10: | Ain Chrob | AMX-AMC-TIC-PIP-TZP-CFS-FOX-CRO-CTX-CAZ-FEP-ATM-IMP-TMP-TE-NA | 16 | − | |
| I11: | Ain Chrob | AMX-AMC-TIC-PIP-PTZ-CFS-FOX-CRO-CTX-CAZ-FEP-ATM-IMP-TMP-TE-NA-C | 17 | − | |
| I12: | Ain Chrob | AMX-AMC-TIC-TCC-PIP-PTZ-CFS-FOX-CRO-CTX-CAZ-ATM- FEP-IMP-TMP-TE-NA-C | 18 | − | |
| I13: | Ain Tagourait | − | |||
| I14: | Ain Tagourait | AMX-TIC-TCC-PIP-PTZ-CFS-FOX-CRO-CTX-CAZ-FEP-ATM-IMP-SSS-TMP-TE-CIP-NA-C-RA | 20 | − | |
|
| |||||
| Cefotaxime-resistant isolates | C1: | Ain Chrob | AMX-TIC-CRO-CTX-SSS-TMP-SXT-C | 8 | + |
| C2: | Ain Chrob | AMX-AMC-TIC-TCC-CFS-FOX-CRO-CTX-ATM-NA | 10 | − | |
| C3: | Ain Chrob | AMX-AMC-TIC-TCC-CFS-FOX-CRO-CTX-ATM-TMP-NA | 11 | − | |
| C4: | Mouth of Reghaia lake | AMX-AMC-TIC-TCC-CFS-FOX-CRO-CTX-CAZ-ATM-NA | 11 | − | |
| C5: | Mouth of Reghaia lake | AMX-AMC-TIC-TCC-CFS-FOX-CRO-CTX-CAZ-ATM-C | 11 | − | |
| C6: | Mouth of Reghaia lake | AMX-AMC-TIC-TCC-FOX-CRO-CTX-ATM-TMP-NA-C | 11 | − | |
| C7: | Ain Chrob | AMX-AMC-TIC-TCC-CFS-FOX-CRO-CTX-FEP-ATM-NA | 11 | − | |
| C8: | Mouth of Reghaia lake | AMX-AMC-TIC-TCC-CFS-FOX-CRO-CTX-ATM-TMP-NA | 11 | − | |
| C9: | Mouth of Reghaia lake | AMX-AMC-TIC-TCC-CFS-FOX-CRO-CTX-CAZ-ATM-TMP-NA | 12 | − | |
| C10: | Mouth of Reghaia lake | − | |||
| C11: | Ain Chrob | AMX-AMC-TIC-TCC-CFS-FOX-CRO-CTX-ATM-IMP-TMP-NA | 12 | − | |
| C12: | Mouth of Reghaia lake | AMX-AMC-TIC-TCC-CFS-FOX-CRO-CTX-ATM-TMP-NA-C | 12 | − | |
| C13: | Mouth of Reghaia lake | AMX-AMC-TIC-TCC-CFS-FOX-CRO-CTX-CAZ-FEP-TMP-NA | 12 | − | |
| C14: | Mouth of Reghaia lake | − | |||
| C15: | Mouth of Reghaia lake | AMX-AMC-TIC-TCC-CFS-FOX-CRO-CTX-CAZ-ATM-TMP-NA-C | 13 | − | |
| C16: | Mouth of Reghaia lake | AMX-AMC-TIC-TCC-CFS-FOX-CRO-CTX-ATM-TMP-TE-NA-C | 13 | − | |
| C17: | Mouth of Reghaia lake | AMX-AMC-TIC-TCC-PIP-FOX-CRO-CTX-CAZ-ATM-TMP-SXT-TE-NA | 14 | − | |
| C18: | Ain Chrob | AMX-AMC-TIC-TCC-PIP-PTZ-CFS-FOX-CRO-CTX-CAZ-FEP- ATM-TMP-C | 15 | − | |
| C19: | Mouth of Reghaia lake | AMX-AMC-TIC-TCC-CFS-FOX-CRO-CTX-CAZ-FEP-ATM-TMP-SXT-TE-NA-C | 16 | − | |
| C20: | Ain Chrob | AMX-AMC-TIC-CFS-FOX-CRO-CTX-CAZ-FEP-ATM-K-SSS-TMP-SXT-TE-NA-C | 17 | − | |
AMX, amoxicillin; AMC, amoxicillin/clavulanate; TIC, ticarcillin; TCC, ticarcillin/clavulanate; PIP, piperacillin; PTZ, piperacillin/tazobactam; CFS, cefsulodine; FOX, cefoxitin; CRO, ceftriaxone; CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepim; ATM, aztreonam; IMP, imipenem; K, kanamycin; GM, gentamycin; SSS, sulfonamide; TMP, trimethoprim; SXT, Trimethoprim/Sulfamethoxazole; TE, tetracycline; CIP, ciprofloxacin; NA, nalidixic acid; C, chloramphenicol; RA, rifampicin.
Fig. 2PCR products of blaCTX-M gene (A) and map of the nucleotide sequence of blaCTX-M-15 gene (B)
A: Detection of blaCTX-M gene with consensus primers for family (left) and group 1 (right) in ESBL-positive E. coli (C1) and in its transconjugants (T1 and T2). The amplification band size of the blaCTX-M family is 550 bp and for group 1 blaCTX-M is 863 bp.
C−: negative control; C+: positive control; M: 100 bp DNA marker.
B: Map of the nucleotide sequence of the 3′ end of ISEcp1 and blaCTX-M-15 and schematic representation of ISEcp1- blaCTX-M-15.
The sequences at the 3′ and 5′ of the primers used for sequencing are underlined.
P-10: sequence of CTX-M-15 promoter region, IR-R: right inverted repeat of ISEcp1, sequence W: intercalary sequence of 48 bp (underlined) between ISEcp1 and blaCTX-M-15. Initiation and stop codons of blaCTX-M-15 are boxed in grey.
Fig. 3Plasmid profiles of ESBL-positive E. coli (C1) and its transconjugants (T1 and T2).
M1: pRK2048 (48 kbp) and M2: E. coli V517 (54, 5.6, 5.1, 3.9, 3, 2.7 and 2.1 kbp)